Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A hemangioblastoma that arises from the retina. It is typically a sign of von Hippel-Lindau disease. It may also be seen as an isolated entity without systemic involvement.
Biomarker and diagnostic research for retinal hemangioblastoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
48 publications have been identified in PubMed for retinal hemangioblastoma. Research spans Case Report / Case Series (44%), Review / Meta-Analysis (19%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 21 | 44% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:52 PM UTC
Research summaries |
9 |
19% |
Disease patterns and progression | 7 | 15% |
Clinical study results | 4 | 8% |
Other research | 2 | 4% |
Testing and diagnosis research | 2 | 4% |
Laboratory research | 2 | 4% |
New treatment approaches | 1 | 2% |
Chang J (2026). [PMID: 41948715](https://pubmed.ncbi.nlm.nih.gov/41948715/). *J Kidney Cancer VHL*. [Case Report / Case Series]
Ahmed AM (2026). [PMID: 41443003](https://pubmed.ncbi.nlm.nih.gov/41443003/). *J Fr Ophtalmol*. [Case Report / Case Series]
Kiristioglu MO (2026). [PMID: 41379559](https://pubmed.ncbi.nlm.nih.gov/41379559/). *Eur J Ophthalmol*. [Case Report / Case Series]
Sartore M (2026). [PMID: 42111285](https://pubmed.ncbi.nlm.nih.gov/42111285/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Stephenson KAJ (2026). [PMID: 40914564](https://pubmed.ncbi.nlm.nih.gov/40914564/). *Can J Ophthalmol*. [Clinical Trial Publication]
Naseripour M (2026). [PMID: 41608742](https://pubmed.ncbi.nlm.nih.gov/41608742/). *Ocul Oncol Pathol*. [Review / Meta-Analysis]
Broadhead GK (2026). [PMID: 41964887](https://pubmed.ncbi.nlm.nih.gov/41964887/). *Graefes Arch Clin Exp Ophthalmol*. [Clinical Trial Publication]
Liang L (2026). [PMID: 42145711](https://pubmed.ncbi.nlm.nih.gov/42145711/). *Front Med (Lausanne)*. [Case Report / Case Series]
Bals K (2026). [PMID: 41533848](https://pubmed.ncbi.nlm.nih.gov/41533848/). *Transl Vis Sci Technol*. [Basic Science / Preclinical]
Shettigar M (2026). [PMID: 41993661](https://pubmed.ncbi.nlm.nih.gov/41993661/). *Taiwan J Ophthalmol*. [Review / Meta-Analysis]